ISC Extends Credit Facility
The previous Credit Facility was due to become current debt on the Company's balance sheet in September 2025. As part of the amendment, the term of the Credit Facility has been extended to July 2029. The aggregate amount available under the Credit Facility remains at $250 million. ISC will maintain access to a $150 million accordion option (up from $100 million under the previous agreement), providing the flexibility to upsize the aggregate revolving credit facility to $400 million. In addition, the Credit Facility has been simplified by consolidating the two existing revolving credit facility tranches of $150 million and $100 million into a single facility of $250 million with improved pricing. A change in the covenants will also provide additional balance sheet flexibility to ISC.
As at June 30, 2025 $155.0 million was drawn under the Credit Facility and ISC is committed to deleveraging its balance sheet to a target of 2.0x – 2.5x. The Credit Facility is available on a revolving basis to finance permitted acquisitions and capital expenditures and for general corporate purposes.
Royal Bank of Canada acted as Administrative Agent with RBC Capital Markets and Canadian Imperial Bank of Commerce serving as Joint Lead Arrangers and Joint Bookrunners for the Credit Facility.
About ISC®
Headquartered in Canada, ISC is a leading provider of registry and information management services for public data and records. Throughout our history, we have delivered value to our clients by providing solutions to manage, secure and administer information through our Registry Operations, Services and Technology Solutions segments. ISC is focused on sustaining its core business while pursuing new growth opportunities. The Class A Shares of ISC trade on the Toronto Stock Exchange under the symbol ISC.
Cautionary Note Regarding Forward-Looking Information
This news release contains certain forward-looking information within the meaning of applicable Canadian securities legislation including, without limitation, statements related to growth opportunities, future financial results (including revenue and adjusted EBITDA), and the availability of credit under the Credit Facility. Such forward-looking information does not represent actual performance or results and is not a guarantee of future outcomes Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those expressed or implied by such forward-looking information. Important factors that could cause actual results to differ materially from the Company's plans or expectations include risks related to changes in economic, market and business conditions, technological development, shifts in customer demands and expectations, reliance on key customers and licences, dependence on key projects and clients, the ability to secure new business and manage fixed-price contracts, identification of viable growth opportunities, execution of the Company's growth strategy, competition, termination risks and other risks disclosed from time to time in the Company's filings including those detailed in ISC's Annual Information Form for the year ended December 31, 2024 and ISC's unaudited Condensed Consolidated Interim Financial Statements and Notes and Management's Discussion and Analysis for the quarter ended June 30, 2025, copies of which are filed on SEDAR+ at
www.sedarplus.ca
. The assumptions underlying, and expectations reflected in, such forward-looking information are based on the assessments and reasonable beliefs of ISC management as of the date of this release and are considered reasonable in the circumstances.
The forward-looking information in this release is made as of the date hereof and, except as required under applicable securities legislation, ISC assumes no obligation to update or revise such information to reflect new events or circumstances.
Investor Contact
Jonathan Hackshaw
Senior Director, Investor Relations & Capital Markets
Toll Free: 1-855-341-8363 in North America or 1-306-798-1137
investor.relations@isc.ca
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Jim Cramer on Agnico Eagle: 'One of the Best Operators in Space, Maybe the Best'
Agnico Eagle Mines Limited (NYSE:AEM) is one of the stocks that Jim Cramer spoke about. During the episode, Cramer called the company his 'favorite.' He said: 'The price of gold has been on an incredible run this year, but some of the gold miners have done even better. Take Agnico Eagle Mines, my favorite, the Canadian company, that's one of the best operators in space, maybe the best. Here's a stock that's up almost 58% for the year, going into its earnings report last night, so expectations, I'd say pretty sky high, but Agnico Eagle still delivered a terrific top and bottom line beat with a stunning level of free cash flow generation. If the stock hadn't been up already so much, I think it would've just skyrocketed. Still, it finished at 0.80% up.' Copyright: tomas1111 / 123RF Stock Photo Agnico Eagle Mines (NYSE:AEM) is a gold mining company involved in the exploration, development, and production of gold and other precious metals, including silver, zinc, and copper. While we acknowledge the potential of AEM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a minute ago
- Yahoo
Pharmaceutical Excipients Market Size Forecasted to Surpass USD 15.43 Billion by 2034 Amid Rising Demand for Novel Drug Delivery Systems
The global pharmaceutical excipients market size is on track to exceed USD 15.43 billion by 2034, rising from USD 9.31 billion in 2025 at a CAGR of 5.75%, according to a new report by Precedence Research. Ottawa, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The worldwide pharmaceutical excipients market size was valued at USD 8.82 billion in 2024, and it is expected to attain USD 15.43 billion by 2034. The growing pharmaceutical industry and increasing demand for biologic and generic drugs drive the market growth. The market is undergoing a significant transformation, driven by the rise of biologics, demand for personalized medicine, and innovations in drug delivery systems. With the market expected to grow at a CAGR of 5.75% from 2025 to 2034, companies across the value chain are eyeing excipients as a critical component for competitive advantage. Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for Before You Buy – Get the Sample Report@ Pharmaceutical Excipients Market Key Takeaways The pharmaceutical excipients market size reached USD 8.82 billion in 2024. It is expected to exceed USD 15.43 billion by 2034. The market is growing at a CAGR of 5.75% between 2025 and 2034. The North American market size was calculated at USD 3.15 billion in 2024. North America accounted for the largest market share of 38.32% in 2024. By excipient type, the lactose-based excipients contributed the biggest market share of 41.26% in 2024. By functionality, the fillers and diluents segment generated the major market share in 2024. By functionality, the coating agents segment is expected to grow at a significant CAGR from 2025 to 2034. By excipient type, the lactose-based segment captured the highest market share 2024. By excipient type, the cellulose-based segment is projected to grow at a notable CAGR from 2025 to 2034. Pharmaceutical Excipients Market Overview What are Pharmaceutical Excipients? Pharmaceutical excipients are inactive substances formulated for drug production. They are used alongside active pharmaceutical ingredients. Pharmaceutical excipients prevent degradation and enhance the absorption of the drug. They are widely used in the production of capsules, tablets, and other drugs. They enhance the appearance, taste, texture, and compressibility of medications. Pharmaceutical excipients offer bulk to medication formulations and improve safety, efficacy, & stability of drugs. They are widely used in formulations of tablets, liquid dosage forms, capsules, creams, and ointments. 'As pharmaceutical companies strive for innovation in formulations and cost-effective manufacturing, multifunctional excipients are emerging as game-changers,' said Deepa Pandey, Principal Consultant at Precedence Research. Top Pharmaceutical Excipients Name Role Examples Diluents Provides Bulk to Formulation Microcrystalline Cellulose Calcium Phosphate Lactose Starch Binders Hold Powdered Ingredients Together Hydroxypropyl Cellulose Polyethylene Glycol Povidone Microcrystalline Cellulose Gelatin Disintegrants Break Up Tablets into Smaller Parts in Liquid Form Starch Croscarmellose Sodium Sodium Starch Glycolate Lubricants Avoid Sticking of Ingredients to Equipment Stearic Acid Magnesium Stearate Glidants Enhance Powder Mixture Flow Talc Colloidal Silicon Dioxide ➤ Get the Full Report @ Pharmaceutical Excipients Market Opportunity What is the Opportunity for the Pharmaceutical Excipients Market? The Growing Demand for Multifunctional Excipients The increasing demand for multifunctional excipients in the pharmaceutical industry for the production of pharmaceutical products creates an opportunity for the market. The growing focus on enhancing drug performance and simplifying drug formulation processes increases demand for multifunctional excipients. The increasing focus on reducing manufacturing costs and improving compliance fuels demand for multifunctional excipients. The focus on the development of sustained-release formulations and fast-dissolving tablets increases the need for multifunctional excipients. The increasing focus on personalised medicines and rapid growth in the biopharmaceutical industry increases demand for multifunctional excipients. The expansion of the healthcare industry and the growing demand for various medications are fueling demand for multifunctional excipients. The growing demand for stabilizing, binding, and disintegrating in one form fuels demand for multifunctional excipients. The growing demand for multifunctional excipients unlocks an opportunity for the growth of the pharmaceutical excipients market. For instance, the development of orally disintegrating tablets has driven demand for excipients that combine binding, taste-masking, and rapid disintegration in a single material. Limitations and Challenges in the Pharmaceutical Excipients Market Why is Pharmaceutical Excipients Development Cost High? Despite several applications of pharmaceutical excipients, the high development cost restricts the market growth. Factors like complex manufacturing processes, stringent regulatory environments, production scaling up, and extensive testing increase the development cost. The need for extensive research & development for the development of drugs increases the cost. The extensive processes like regulatory approval, research time, and testing increase the development cost. Complex manufacturing processes and the need for specialized equipment lead to higher development costs. The need for higher investment in large-scale manufacturing and lengthy development, and complex testing directly impacts the market. The regulatory approvals, like extensive evaluations and approval from regulatory bodies, increase the cost. The high development cost hampers the growth of the pharmaceutical excipients market. The timing has never been more critical. With global emphasis on rapid drug development, personalized medicine, and biologic therapies, pharmaceutical excipients are no longer passive ingredients but active enablers of innovation, efficacy, and compliance. Scope of Pharmaceutical Excipients Market Report Attributes Statistics Market Size in 2024 USD 8.82 Billion Market Size in 2025 USD 9.31 Billion Market Size by 2034 USD 15.43 Billion CAGR 2025 to 2034 5.75% Leading Region in 2024 North America (accounted for 38.32% of market share) Fastest Growing Region Europe Base Year 2024 Forecast Period 2025 to 2034 Segments Covered Functionality, Excipient Type, and Regions Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa ➡️ Become a valued research partner with us ☎ Case Study: Multifunctional Excipients Streamline Tablet Production for Generic Drug Manufacturer In 2024, a leading Indian generic pharmaceutical company adopted a multifunctional excipient combining binding, disintegration, and flow-enhancing properties in a reformulated version of its high-volume antihypertensive tablet. Key Outcomes: Reduced formulation steps by 30%, minimizing the use of multiple individual excipients. Cut production costs by 18% through improved compression and faster manufacturing cycles. Achieved 25% faster dissolution rate, improving patient compliance and therapeutic onset. Streamlined regulatory submission, thanks to excipient's prior GRAS (Generally Recognized As Safe) status and established supplier documentation. This case demonstrates the cost and performance benefits driving global demand for multifunctional excipients, particularly among high-volume, cost-sensitive drug manufacturers. Gain a competitive edge in formulation and drug delivery our pharma research team at sales@ or book a 1:1 session to unlock segment-specific insights. Pharmaceutical Excipients Market Key Regional Insights How Did North America Dominate Pharmaceutical Excipients Market in 2024? North America dominated the pharmaceutical excipients market in 2024, owing to the strong presence of a well-developed and advanced pharmaceutical industry in the region increases the demand for pharmaceutical excipients for the production of drugs. The extensive investment in research & development of pharmaceuticals helps in the market growth. The growing demand for generic drugs increases demand for pharmaceutical excipients. The increasing development of advanced drug formulations and drug delivery systems increases demand for pharmaceutical excipients. The stringent regulations for the development of excipients help the market growth. The increasing demand for personalised medicines and focus on biologics drive the market growth. U.S. Pharmaceutical Excipients Market Size and Forecast 2025 to 2034 How big is the U.S. Pharmaceutical Excipients Market? According to Precedence Research, the U.S. pharmaceutical excipients market size reached USD 2.90 billion in 2024 and is expected to grow from USD 3.08 billion in 2025 to USD 5.32 billion by 2034, registering a CAGR of 6.26% from 2025 to 2034. Key Market Drivers and Insights Strong generics penetration in the U.S. elevates demand for excipients, especially in oral dosage forms like tablets and capsules. Advanced formulations, including controlled-release and biopharma delivery systems, are boosting growth in high-performance excipients and coating agents. Regulatory clarity and infrastructure investment maintain the region's dominance, with substantial R&D in U.S.-based excipient solutions. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ How is Asia Pacific the Fastest Growing in the Pharmaceutical Excipients Market? Asia Pacific is experiencing the fastest growth in the market during the forecast period, owing to the growing healthcare spending and rising demand for various pharmaceutical products that increase the demand for pharmaceutical excipients. The increasing expansion of generic drugs helps the market growth. The focus on personalised medicines and advancement in drug delivery systems fuels demand for pharmaceutical excipients. The strong government support for the pharmaceutical industry and growing investment in R&D help the market growth. The rise in biosimilars & biologics and the expansion of nutraceuticals support the market growth. Top Three Asian Exporters of Pharmaceutical Excipients: Countries Export Leading Suppliers Japan 356 Shipments SHIN ETSU CHEMICAL CO, LTD China 200 Shipments WELLSTARS INTERNATIONAL CO, LTD India 106 Shipments Amtec Health Care Pvt Ltd (Source: Pharmaceutical Excipients Market Segmentation Analysis: Functionality Analysis Why did Fillers and Diluents Segment Dominate the Pharmaceutical Excipients Market? The fillers and diluents segment dominated the pharmaceutical excipients market in 2024. The easy availability of different forms and grades of fillers and diluents helps the market growth. The need for achieving the desired weight & size of capsules & tablets increases demand for fillers & diluents. They contribute to tablet content uniformity and improve the flow properties of tablet formulations. Fillers & diluents enhance production efficiency, tablet compression, and flow properties. The growing demand for different starches, lactose, and microcrystalline fillers & diluents drives the market growth. The coating agent segment is significantly growing in the market during the forecast period. The growing focus on improving patient experience increases demand for coatings to cover up the unpleasant odor and taste of medications. The increasing demand for protecting active ingredients in pharmaceutical production fuels demand for coating agents. The growing prevalence of chronic diseases increases demand for coated medications. Coating agents enhance drug delivery and control drug release in the body. The rising adoption of oral solid medications like capsules & tablets supports the market growth. Excipient Type Analysis How Lactose-Based Segment Held the Largest Share of the Pharmaceutical Excipients Market? The lactose-based segment held the largest revenue share of the pharmaceutical excipients market in 2024 due to growing demand for binder, flow agent, filler, and diluent in various pharmaceutical applications that increases demand for lactose-based excipients. They are available in various forms like spray-dried, anhydrous, & monohydrate and are compatible with various APIs. Lactose-based excipients have good flowability, low hygroscopicity, excellent compressibility, and good solubility. They are easily available and cost-effective for pharmaceutical production. The increasing demand across applications like lyophilization, solid dosage forms, and inhalation products drives the market growth. The cellulose-based segment is significantly growing in the market during the forecast period. The growing demand for cellulose-based excipients across various pharmaceutical applications like controlled-release formulations, tablet binding, and disintegration helps the market growth. The increasing demand for generic drugs fuels demand for cellulose-based excipients. They are derived from a plant source and improve the bioavailability of less soluble drugs. The growing development of patient-friendly drug delivery systems and orally dissolving tablets supports the market growth. ✚ Related Topics You May Find Useful ➤ ➡️Pharmaceutical Manufacturing Market: Advancing efficiency through automation, AI, and global capacity expansion ➡️Pharmaceutical Chemicals Market: Meeting rising API demand with stringent quality and compliance standards ➡️Nutraceutical Excipients Market: Enhancing bioavailability and stability with clean-label formulations ➡️High-Potency API Market: Enabling targeted therapies for oncology and rare diseases ➡️Biotech Ingredients Market: Supporting biologics growth with innovative, high-purity ingredients ➡️Pharmaceutical Intermediates Market: Accelerating complex drug development via outsourcing and specialty production ➡️Pharma Contract Manufacturing & Research Market: Strengthening drug pipelines with advanced outsourcing solutions Pharmaceutical Excipients Market Top Companies The pharmaceutical excipients market is dominated by key players who collectively command the largest market share and significantly influence industry trends. Ashland Global Holdings BASF SE DuPont Roquette Feres Evonik Industries AG Associated British Foods Archer Daniels Midland Company Lubrizol Corporation Croda International Kerry Group Recent Developments In November 2024, Clariant launched new high-performing excipients for effective medicines. The excipients are available for various applications like parenteral formulations and sensitive active pharmaceutical industries. The range offers high-quality, tailored, reliable, and cost-effective solutions for the healthcare sector in India. (Source: In January 2025, GELITA launched Endotoxin Controlled Excipients for pharmaceutical and bioscience applications. The product range includes MEDELLAPRO and VACCIPRO, that used in applications like 3D bioprinting, vaccine stabilisation, and medical devices. The excipients ensure patient safety and well-being. (Source: In December 2023, Roquette launched three new excipient grades, MICROCEL 113 SD, LYCATAB CT-LM, and MICROCEL 103 SD. The new excipients support the development of drugs and focus on improving the experience of producers & patients. (Source: In May 2025, Pharcos Specialty Ltd launched India's first homegrown hydroxypropyl methylcellulose excipients for the pharmaceutical industry. The excipients are used in the coating of tablets & pellets, stabilization of suspensions, thickening agent in pharmaceutical formulations, controlled-release matrix system, wet granulation & binder system, manufacturing vegetarian tablets, and frozen food & food dietary. (Source: Pharmaceutical Excipients Market Segments Covered in the Report By Functionality Fillers and Diluents Suspending and Viscosity Agents Coating Agents Binders Disintegrants Colorants Lubricants and Glidants Preservatives Emulsifying Agents Flavoring Agents and Sweeteners Other Functionalities By Excipient Type Lactose-based Excipients α-lactose monohydrate Anhydrous α-lactose Anhydrous β-lactose Amorphous Lactose Cellulose-based Microcrystalline Cellulose (MCC) Cellulose Ethers Others Starches Carboxymethylcellulose Sodium (CCS) Sodium Starch Glycolate (SSG) Fine Chemicals Mannitol Biopharma Excipients Others By Region North America U.S. Canada Europe Germany UK France Italy Spain Sweden Denmark Norway Asia Pacific China Japan India South Korea Thailand Latin America Brazil Mexico Argentina Middle East & Africa South Africa UAE Saudi Arabia Kuwait Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as Immediate Delivery Available | Buy This Premium Research Report@ You can place an order or ask any questions, please feel free to contact at sales@ | +1 804 441 9344 Stay Ahead with Precedence Research Subscriptions Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve. Browse Our Subscription Plans@ About Us Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. Web: Our Trusted Data Partners: Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor | Market Stats Insight Get Recent News: For the Latest Update Follow Us: LinkedIn | Facebook | TwitterError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Complex Commercial Vehicle Market Shows Signs of Recovery
Dealers face new challenges as inventory stabilizes and buyer choices expand New Commercial Vehicle Trends Trends for Used Work Trucks and Vans Chico, CA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Work Truck Solutions®, the leading commercial vehicle authority, has released its Q2 2025 Commercial Vehicle Market Analysis, highlighting continued strength in the new commercial vehicle market and its ripple effects across the used sector. With inventory level stabilization, the commercial vehicle ecosystem is showing signs of healthy alignment—as robust new vehicle sales are beginning to replenish used inventory and drive movement across both segments. Switch Auto Insurance and Save Today! Affordable Auto Insurance, Customized for You The Insurance Savings You Expect Great Rates and Award-Winning Service New Work Truck and Van Market New vehicle pricing continued its gradual rise, with the average final price increasing by 0.4% quarter-over-quarter (QoQ) and 0.3% year-over-year (YoY) to $59,842. On-lot inventory per dealer dipped slightly from Q1 (down 0.6%) but remains significantly higher year-over-year (up 14.7%). Sales activity picked up, with units moved per dealer rising 12.5% from Q1 and 35.0% year-over-year, reflecting operational demand, as well as a likely number of pull-ahead sales due to tariff concerns. Still, Days-to-Turn (DTT) rose again—up 17.4% from last quarter and 69.7% compared to Q2 2024—revealing slower commercial vehicle inventory turns despite higher sales as pockets of inventory remain mismatched to their market demand. Used Work Truck and Van Market Used vehicle pricing continued to soften, falling 1.7% from Q1 and 2.9% year-over-year to an average final price of $34,456. Used inventory per dealer remained nearly flat compared to the first quarter of the year, after dipping in the final two quarters of 2024, while sales ticked upward by 4.5% QoQ and 10.5% YoY. Despite an anomalous uptick in Q1 2025, DTT, as expected, continued to decline overall, dropping 5.6% YoY. Median mileage of used commercial trucks and vans dropped 10.8% QoQ, but is still up 5.1% YoY. The quarterly drop in mileage is likely a result of more businesses trading in fleet vehicles in general, and doing so earlier than during the 'pandemic era' when on-lot inventories were dramatically impacted by supply challenges. Commercial BEV/HEV Market Insights New commercial battery electric and hybrid vehicle (BEV/HEV) pricing saw a substantial uptick, with new prices rising 1.8% QoQ and 19.1% YoY to an average of $57,513. Conversely, used commercial vehicle prices in this segment fell 0.64% QoQ and 3.7% YoY. As more alternative fuel vehicles come into the market, Work Truck Solutions will offer further insights into the commercial BEV/HEV sector. Industry Perspective 'Although sales across most body types remain strong, the continued rise in new vehicle Days-to-Turn tells an important story,' said Aaron Johnson, CEO of Work Truck Solutions. 'While not a slowdown, there are more vehicles on the lot, more choices for buyers, and more competition among commercial vehicle dealers.' Johnson continued, saying, 'For dealerships, this means the landscape is shifting. Success will hinge on how well they differentiate and adapt—whether through pricing strategies, inventory mix, digital merchandising, or more likely, a combination of all of these. The same tools that helped dealers thrive during leaner inventory times are at least as essential, if not more so, in an environment of increased competition. Visibility, agility, and customer engagement aren't just advantages—they're requirements.' About Work Truck SolutionsWork Truck Solutions provides a smart technology platform that enables all stakeholders in the commercial vehicle ecosystem - dealers, OEMs, upfitters, and distributors - to efficiently serve the businesses and fleet managers who need work trucks and vans. With innovative solutions covering numerous areas such as one-stop inventory management, operational analytics, and digital marketing, Work Truck Solutions helps those in the commercial vehicle space, no matter their role in the supply chain, increase visibility and efficiency so businesses can focus on doing their jobs. Attachments New Commercial Vehicle Trends Trends for Used Work Trucks and Vans CONTACT: Steve Henning Work Truck Solutions 530-718-1885
